Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a postemergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The Company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases.

TypePublic
HQDavis, US
Founded2006
Size (employees)97 (est)
Websitemarronebioinnovations.com
Marrone Bio Innovations was founded in 2006 and is headquartered in Davis, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Marrone Bio Innovations

Pam Marrone

Pam Marrone

Founder and CEO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs
Show more

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave
Show all (2)
Report incorrect company information

Marrone Bio Innovations Financials and Metrics

Marrone Bio Innovations Revenue

Marrone Bio Innovations's revenue was reported to be $14.04 m in FY, 2016 which is a 43.3% increase from the previous period.
USD

Revenue (Q2, 2018)

10.1m

Net income (Q2, 2018)

(7.8m)

EBIT (Q2, 2018)

(10.0m)

Market capitalization (15-Oct-2018)

186.9m

Closing stock price (15-Oct-2018)

1.7

Cash (30-Jun-2018)

23.3m

EV

166.3m
Marrone Bio Innovations's current market capitalization is $186.9 m.
Annual
USDFY, 2013Y, 2014FY, 2015FY, 2016

Revenue

14.5m1.1m9.8m14.0m

Revenue growth, %

(92%)793%43%

General and administrative expense

18.5m

Operating expense total

18.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

1.3m2.8m3.6m2.1m3.4m2.5m2.7m5.0m3.6m4.2b6.5b4.2m4.3m10.1m

General and administrative expense

4.5m6.3m6.0m7.9m7.4m5.3m5.5m4.5m3.8m5.3b5.1b5.2m5.0m9.7m

R&D expense

4.5m

Operating expense total

8.9m10.6m10.3m11.3m10.7m8.8m7.9m6.8m6.4m7.8b7.9b8.3m7.6m14.8m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

24.5m35.3m19.8m9.6m

Accounts Receivable

6.2m1.8m2.3m3.6m

Inventories

1.7m1.3m1.3m8.5m

Current Assets

58.7m54.7m36.0m26.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

40.8m21.3m57.6m22.4m12.2m27.8m9.8m21.2m16.0m1.8m10.2m3.7m14.8m23.3m

Accounts Receivable

2.1m7.2m4.1m2.2m3.0m1.4m4.7m4.5m2.1m8.1m5.8m1.9m4.4m4.7m

Inventories

10.8m12.8m12.5m11.8m10.6m9.8m8.6m8.0m8.4m8.1m8.4m9.3m10.0m9.2m

Current Assets

68.6m47.0m80.1m41.1m30.2m43.4m28.1m37.8m30.6m24.4m29.6m19.5m30.4m38.0m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.5m)(16.2m)(43.7b)(31.1m)

Depreciation and Amortization

976.0k2.2m

Inventories

(6.8m)1.3m582.0k

Accounts Payable

1.7m5.8m(588.0k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(6.1m)(10.2m)(10.4m)(11.9m)(22.9m)(32.7m)(9.3m)(16.1m)(23.3m)(7.6b)(2.9m)(7.8m)

Depreciation and Amortization

833.0k1.7m2.6m594.0k1.2m1.7m478.0k983.0k

Inventories

869.0k2.0m2.9m504.0k1.1m659.0k(220.0k)646.0k

Accounts Payable

8.6m5.2m(1.6m)(2.3m)(4.4m)583.0k196.0k223.0k3.0m(1.1m)(2.2m)
USDY, 2018

EV/EBIT

-16.7 x

EV/CFO

-11.1 x

Financial Leverage

2.5 x
Show all financial metrics
Report incorrect company information

Marrone Bio Innovations Online and Social Media Presence

Embed Graph
Report incorrect company information

Marrone Bio Innovations News and Updates

Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam

Regalia® , Grandevo®  and Majestene®  to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins

Marrone Bio Innovations, Inc. Reports Second Quarter 2018 Financial Results

Company Achieves Several Key Milestones, Continues International Expansion and Improves Gross Margins 850 Basis Points to 47.3% Company Achieves Several Key Milestones, Continues International Expansion and Improves Gross Margins 850 Basis Points to 47.3%

Marrone Bio Innovations Submits Novel Bioherbicide to the EPA for Regulatory Approval

DAVIS, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, has submitted the registration package for its new bio…
Report incorrect company information

Marrone Bio Innovations Blogs

Marrone Bio Innovations Appoints Barner Jones as New Director of National Sales and Account Management

DAVIS, Calif., Oct 17, 2018 – Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Barner Jones has joined as Director of National Sales and Account Management. Mr. Jones, a licensed Pest Control Ad…

Meet the Bug-Loving Entrepreneur Who Kills Pests Without Poison

The Story Exchange | Christina Kelly | Article Link | Oct 9, 2018 Entomologist Pam Marrone has turned a fascination with insects into Marrone Bio Innovations Inc., a publicly traded company that develops natural pest-control products as alternatives to controversial pesticides. The Davis, California…

Marrone Bio Innovations Investor Presentation Sept. 13, 2018

Click here to view on HC Wainwright site Marrone Bio Innovations, Inc. (Nasdaq: MBII) Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; ne…

Marrone Bio Innovations Named to 2018 Agrow Awards Shortlist

MBI Named Finalist for Best R&D Pipeline, Best New Biological Product (Biopesticide) and Best Industry Collaboration Categories DAVIS, Calif., Sept. 25, 2018 – Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, ha…

INSIGHT: Biopesticides to Feed a Growing and Hungry World

Bloomberg Environment | Dr. Pam Marrone | Sept 24, 2018 | Article Link Whether it is in China, Guatemala, Brazil, Europe, or the U.S., consumers, and especially young people, want more information and transparency about how crops are grown and how their food is produced. Food companies are taking no…

The Short List on YouTube with Cristine Mendonsa & Pam Marrone

Biological Solutions for Asian Citrus Psyllid Relief
Show more

Marrone Bio Innovations Company Life and Culture

Report incorrect company information